top of page

News & Updates

Filter by:

Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia

News & Updates

12 Jan 2026

Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia

Read More
Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

News & Updates

30 May 2025

Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

Read More
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

News & Updates

24 Feb 2025

Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

Read More
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

News & Updates

10 Jan 2025

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

Read More
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

News & Updates

2 Jan 2025

Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

Read More
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics
Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans

News & Updates

28 Oct 2024

Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans

Read More
Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans
Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types

News & Updates

2 Oct 2024

Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types

Read More
Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting

News & Updates

4 Jul 2024

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting

Read More
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

News & Updates

26 Feb 2024

Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

Read More
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

1

/

4

bottom of page